Scedosporium infection in a tertiary care cancer center: A review of 25 cases from 1989-2006

Clinical Infectious Diseases

Volumn 43, Issue 12, 2006, Pages 1580-1584

  Lamaris, Gregory A ^a   Chamilos, Georgios ^a   Lewis, Russell E ^a   Safdar, Amar ^a   Raad, Issam I ^a   Kontoyiannis, Dimitrios P ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; CORTICOSTEROID; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; PREDNISONE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER PATIENT; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; MYCOSIS; NEUTROPHIL COUNT; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SCEDOSPORIUM; TREATMENT OUTCOME;

ADULT; AGED; CANCER CARE FACILITIES; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; MADUROMYCOSIS; MALE; MIDDLE AGED; NEOPLASMS; SCEDOSPORIUM;

EID: 33845452792     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/509579     Document Type: Article

References (16)

1. Torres H, Kontoyiannis DP. Hyalohyphomycoses. In: Dismukes WE, Pappas PG, Sobel JD, eds. Oxford textbook of clinical mycology. New York: Oxford University Press, 2003:252-70.
2. Husain S, Munoz P, Forrest G, et al. Infections due to Scedosporium apiospermium and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 2005; 40:89-99.
3. Idigoras P, Perez-Trallero E, Pineiro L, et al. Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990-1999. Clin Infect Dis 2001; 32:E158-65.
4. Panackal AA, Marr KA. Scedosporium/Pseudallescheria infections. Semin Respir Crit Care Med 2004; 25:171-81.
5. Castiglioni B, Sutton DA, Rinaldi MG, Fung J, Kusne S. Pseudallescheria boydii (anamorph Scedosporium apiospermum): infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine 2002; 81:333-48.
6. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34:909-17.
7. Baddley JW, Stroud TP, Salzman D, Pappas PG. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis 2001; 32:1319-24.
8. Maertens J, Lagrou K, Deweerdt H, Surmont I, Verhoef GEG, Verhaegen J. Disseminated infection by Scedosporium prolificans: an emerging fatality among hematology patients. Case report and review. Ann Hematol 2000; 79:340-4.
9. Lionakis MS, Kontoyiannis DP. The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer. Cancer 2004; 100:165-72.
10. Lionakis MS, Bodey GP, Tarrand JJ, Raad II, Kontoyiannis DP. The significance of blood cultures positive for emerging saprophytic moulds in cancer patients. Clin Microbiol Infect 2004; 10:922-5.
11. Boucher HW, Groll AH, Chiou CC, Walsh TJ. Newer systemic antifungal agents: pharmacokinetics, safety and efficacy. Drugs 2004; 64:1997-2020.
12. Guarro J, Kantarcioglu AS, Horre R, et al. Scedosporium apiospermum: changing clinical spectrum of a therapy refractory opportunist. Med Mycol 2006; 44:295-327.
13. Larone DH. Medically important fungi: a guide to identification. 4th ed. Washington, DC: American Society for Microbiology Press, 2002.
14. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34:7-14.
15. Perfect JR, Marr KA, Walsh TJ, et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003; 36:1122-31.
16. Hachem R, Graybill JR, Negroni R, et al. Posaconazole as salvage therapy for Pseudallescheria infections: a case series [abstract 510]. In: Proceedings of the 14th European Congress of Clinical Microbiology and Infectious Diseases (Prague, Czech Republic). 2004.